chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse concerning a 24 year old female patient with no known drug allergies and no pertinent medical history who on 08-APR-2003, 05-AUG-2004 and 16-JUN-2005 was vaccinated with the first, second and third doses of adult RECOMBIVAX HB. There was no concomitant medication. Subsequently, the patient was found to have anti-HBs concentration of <5mIU/mL after the primary vaccine series with RECOMBIVAX HB. The patient sought unspecified medical attention and the serum hepatitis B surface antibody screen was performed. At the time of the report, the patient's outcome was unknown. Follow-up information has been received from a registered nurse who reported that the 24 year old female patient was not a smoker. On 01-FEB-2010, the patient had a serum hepatitis B surface antibody screen performed which showed that the anti-HBs concentration was less than 5mIU/mL. The patient had a lack of seroconversion. On 22-FEB-2010 and 24-MAR-2010, the patient had unspecified booster vaccines (lot# AHBVBB34AA). At the time of the report, the patient's outcome was unknown. Additional information is not expected.
Tonight started getting really bad tinnitus in my right ear only, and pulsing.  Never had that like this before so loud and pulsing, Checked online and a lot of people are reporting that as a side effect.  it only started an hour ago  so nothing else to report yet, i'm assuming it's temporary.
Red, painful reaction 24 hours after shot left thigh.  Patient seen at 48 hours - 4cm thick, red, raised rash with light pink.  No raised 2cm beyond.  Plus pain, no itch.
Information has been received from a physician via company representative concerning to a patient of unknown age and gender. Concurrent and historical conditions were not reported. Concomitant therapies were not provided. On 30-NOV-2015, the patient was vaccinated with an improperly stored dose of GARDASIL "10x1 sdv" (Lot No. K001631, exp. 24-FEB-2017) (dose and site not reported). On an unspecified date, the GARDASIL vaccine had a temperature excursion of 24 hours. The highest recorded temperature was 48 (8.88888889 Celsius degrees). The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator (R)". No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
Contracted a cold; Sinus infection; Sinus drainage  in throat; Tenderness around the shot area; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Contracted a cold), SINUSITIS (Sinus infection), UPPER-AIRWAY COUGH SYNDROME (Sinus drainage  in throat) and VACCINATION SITE PAIN (Tenderness around the shot area) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included FLUCONAZOLE for Yeast infection, METFORMIN and GABAPENTIN for an unknown indication.  On 20-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (Contracted a cold), SINUSITIS (Sinus infection), UPPER-AIRWAY COUGH SYNDROME (Sinus drainage  in throat) and VACCINATION SITE PAIN (Tenderness around the shot area). The patient was treated with PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE (EQUATE SINUS DAY TIME) for Sinusitis, at an unspecified dose and frequency and DOXYLAMINE SUCCINATE, PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE (EQUATE SINUS NIGHT TIME) for Sinusitis, at an unspecified dose and frequency. At the time of the report, NASOPHARYNGITIS (Contracted a cold), SINUSITIS (Sinus infection), UPPER-AIRWAY COUGH SYNDROME (Sinus drainage  in throat) and VACCINATION SITE PAIN (Tenderness around the shot area) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   The patient was scheduled for her second dose on 18-Oct-2021.
Initial report received from a healthcare professional on 24 October 2014. This case is linked to cas numbers 2014SA147665 and 2014SA150234 (same reporter). A male patient, whose age was unknown, had received a dose of FLUZONE ID, (batch number, dose number, route and site of vaccination not reported) on an unspecified date. The patient's illness at the time of vaccination, concomitant medications and pre-existing physician diagnosed allergies, birth defects and medical conditions were unknown. On an unspecified date, the patient experienced severe swelling and pain at the injection site that prevented him moving his arm. Corrective treatments were not reported and laboratory details were unknown. At the time of this report, the patient outcome was unknown. Documents held by sender: none.
Muscle pain in the legs; muscle stiffness; muscle spasms; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (muscle stiffness), MUSCLE SPASMS (muscle spasms) and MYALGIA (Muscle pain in the legs) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A and 13A2A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma (condition improved) since 27-Mar-1967.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 05-Mar-2021, the patient experienced MUSCLE SPASMS (muscle spasms). On 06-Apr-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (muscle stiffness). On 07-Apr-2021, the patient experienced MYALGIA (Muscle pain in the legs). The patient was treated with IBUPROFEN ongoing from 03-May-2021 for Muscle pain, at a dose of 200 milligram. At the time of the report, MUSCULOSKELETAL STIFFNESS (muscle stiffness) and MUSCLE SPASMS (muscle spasms) had not resolved and MYALGIA (Muscle pain in the legs) outcome was unknown.            No concomitant and treatment products reported. Action taken with mRNA-1273 in response to the events was Not Applicable.     Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Follow up information was received on 18 May 2021 wherein patient demographics, dose details and events were added.
Within one week after second vaccine shot - cramps, severe diarrhea multiple times per day and nights for a few weeks included 2 ER visits for dehydration and low BP. Gastroenterology determined via fecal tests indicated Pancreatic insufficiency requiring Creon before each meal. Pancreas has not returned to normal function.
Fatigue for 11 days; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue for 11 days) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Fatigue for 11 days). At the time of the report, FATIGUE (Fatigue for 11 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Patient was given Moderna Bivalent vaccine and should have received 2nd dose of Moderna Monovalent.  No side effects.  Patient was informed of incorrect dose and will return for correct vaccine.
Shot in left arm. After about 1 wk pain. Pain size of a dime near shot. Pain spot got larger to size of a silver dollar. Mid December pain to whole arm and neck. Stopped statin to see if that is cause. 2 wks later have pain but 30-40% less. Still off statin. Pain bad.
Information regarding PREVNAR 13 was received from a physician regarding a patient who experienced pain and rash. The patient received a dose in Jun-2010. The patient experienced pain and rash in Jun-2010. Outcome is unknown for both events. No additional information was available at the time of this report.
Information has been received from a healthcare worker concerning a 16 year old female who on 05-NOV-2007 was vaccinated intramuscularly with her first dose of GARDASIL (lot #654540/1209U). There was no concomitant medication. On approximately 20-JAN-2008 the patient developed mononucleosis. The patient's mononucleosis persisted. The healthcare worker did not feel the mononucleosis was related to the use of GARDASIL vaccine. The physician can not be contacted. The patient sought unspecified medical attention by calling the physician.
Friday night(10pm) began to have left arm pain/spasms at Td site. Saturday, progressive general body ache, flu-like achiness. Sunday, whole body ached, swelling of left shoulder, up to neck/face, unable to get out of bed. Monday, decreased achiness, left arm 6" erythema, tender to touch, swollen, warm to touch at Td site
Pain and swelling in right thigh where flu vaccine was administered. Vomiting x 1.
Numbness in hands and arms, feet and legs.  Arms and legs weak.  Physical work or exercise bring on chronic tiredness/weakenss. Headaches and feeling of being disconnected.
Got a blood clot in my right leg on 05Dec, 3 days after the booster shot which almost killed me.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 79-year-old patient received BNT162b2 (BNT162B2), on 03Dec2021 at 12:00 as dose 3 (booster), single (Lot number: FG3527) at the age of 79 years, in right arm for covid-19 immunization. The patient's relevant medical history included: "Known allergies: Sulphur" (unspecified if ongoing), notes: Known allergies: Sulpher. and other medical history: was reported as none Concomitant medication(s) included: FINASTERIDE. Vaccination history included: BNT162b2 (Dose Number: 2, Batch/Lot No: EL9267, Location of injection: Arm Right, Vaccine Administration Time: 01:00 PM), administration date: 19Feb2021, when the patient was 78-year-old, for COVID-19 Immunization; BNT162b2 (Dose Number: 1, Batch/Lot No: EL9263, Location of injection: Arm Right, Vaccine Administration Time: 01:00 PM), administration date: 27Jan2022, when the patient was 78-year-old, for COVID-19 Immunization. The following information was reported: THROMBOSIS (caused and prolonged hospitalization, medically significant, life threatening) with onset 05Dec2021 at 22:30, outcome "recovered with sequelae", described as "Got a blood clot in my right leg on 05Dec, 3 days after the booster shot which almost killed me.". The patient was hospitalized and prolonged hospitalization for thrombosis (hospitalization duration: 3 day(s)). Therapeutic measures were taken as a result of thrombosis. It was reported that the facility type where vaccine was given was Pharmacy or Drug Store and other medications  given in two weeks was Finasteride 5 mg. The treatment given for the event was blood thinners.  No follow-up attempts are possible. No further information is expected.
Fully vaccinated patient tested positive 8/28/2021 and hospitialized then expired 09/03/2021.
On August 8th I got shingles on the left side of my face and head. Having shingles was "no fun at all". I went to Urgent Care on August 12th, and was diagnosed with shingles. I was given a steroid and Valtrex. A few weeks later, I contacted my Primary doctor, and they prescribed Gabapentin for nerve pain in my face. On August 13th I went to the Ophthalmologist because I had the shingles on my eye. My eye looked good, and was given a cream to put on my eye to help with the itching. The shingles did not actually settle into the eye.
BODY ACHES; LIGHTHEADEDNESS; This spontaneous report received from a health care professional concerned a 50 year old female. The patient's height, and weight were not reported.  The patient's concurrent conditions included kidney stones, left breast lump, and seizure disorder, and other pre-existing medical conditions included patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805025 expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 12-APR-2021, the subject experienced body aches. On 12-APR-2021, the subject experienced lightheadedness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, and lightheadedness on 13-APR-2021. This report was non-serious. This case, from the same reporter.
I had pain and soreness from the day I received the vaccine.  However on 10/07/2014 the pain increased greatly.  I have great pain with certain movements of my shoulder and have trouble sleeping.  The pain is not decreasing.
Patient had Varivax 2/18/08 and on 2/20/08 presented with cellulitis. Pt was treated with Augmentin 500mg po BID x 10 days.
PATIENT AND MOTHER CAME IN WEDNESDAY 11.24.21  AFTERNOON FOR COVID BOOSTER. MOTHER REPORTED TO PHARMACY ON FRIDAY 11.26.21 (DEPARTMENT CLOSED THURSDAY 11.25.21) THAT PATIENT HAD STARTED FEELING "UNWELL" (FEVER/TIREDNESS) LATE 11.24.21 / EARLY 11.25.21. MOTHER REPORTED DIDNT THINK MUCH OF IT BUT THAT HER SON (PATIENT) WAS GOING TO REST. MOTHER REPORTED THAT LATER IN THE DAY SON WENT INTO THE BATHROOM AND WAS IN THERE FOR SOME TIME, WHEN SHE WENT TO CHECK ON HIM, SHE COULD NOT GET THE DOOR OPEN. UPON OPENING THE DOOR,  SON WAS FOUND UNRESPONSIVE. ATTEMPTS TO REVIVE SON BY MEDICAL PERSONEL WERE UNSUCCESSFUL. PER MOTHER AN AUTOPSY IS SCHEDULED BUT AS OF REPORTING NO CAUSE OF DEATH HAS BEEN LISTED.
Nausea, some vomiting, slight headache, fatigue, muscle aches all through the night.  Bad enough that I could not sleep.  Nausea was gone in the morning but the muscle aches and the headache and the fatigue continued all the next day.
Pt recvd measles vax 2JAN91 & exp a sore arm for 1 to 2 days following vax; Subsequently pt recovered;
Pt noticed defect in left arm deltoid area MRI showed subtle infiltration of fat in posterolateral aspect of the left arm.
Janssen COVID-19 Vaccine EUA 05/03/2021 and tested positive via nasal swab PCR on 05/29/2021
Patient was observed by mother to be experiencing a seizure. Event occurred around 15 minutes after immunization. Patient was said to have minor "jerking" for 45 seconds and patient hit back on shelf in store and was caught by mother before going completely on the floor. Patient recovered from seizure and was responsive when pharmacist arrived. Patient was observed for additional 20 minutes in pharmacy. Vitals were check and within normal limits. Patient left pharmacy by foot and no other treatment was administered,
Information has been received from a consumer concerning his 16 year old daughter with "brachial plexus" of her right arm which was diagnosed a few years ago, and allergy to viral medications (it caused brachial plexus) who on 01-OCT-2008, 02-DEC-2008 and on 21-APR-2009 was vaccinated with the first, second and third doses (o.5 ml) of GARDASIL (Lot # not reported) respectively. Concomitant medication included "pain medication" (unspecified). It was reported that "after first dose" of GARDASIL the nerve damage on her right arm "flared up". After receiving her second dose of GARDASIL the nerve damage (brachial plexus) occurred on her left arm. It was reported that after receiving her third dose of GARDASIL the nerve pain (brachial plexus) "flare up" on her right arm again. The patient sought unspecified medical attention. There were "numerous laboratory work, MRI" performed (results not provided). It was reported that the patient was recovering at the time of the report. No further information is available.
ARM REALLY HURTS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 205821A, and batch number: 205821A expiry: UNKNOWN) dose was not reported, administered on 18-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On MAY-2021, treatment medications included: ibuprofen, and paracetamol. On 18-MAY-2021, the subject experienced arm really hurts. The action taken with covid-19 vaccine was not applicable. The patient had not recovered from arm really hurts. This report was non-serious.
This spontaneous report was received from a Licensed Practical Nurse referring to a 18 year old (reported as "18.5 years old") female patient. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided. On 15-OCT-2007, the patient received the first dose of GARDASIL (strength, route, anatomical location, lot number and expiration date were not provided)  for prophylaxis. On 14-JAN-2008, the patient received the second dose of GARDASIL and on 01-APR-2008 the patient received the third dose of GARDASIL, however the patient did not experienced an adverse event. Additional information has been requested.
Noticed a little tension to supraclavicular area, then when palpated noticed the swelling
This is a spontaneous report received from a noncontactable other HCP. A patient (no qualifiers provided) received unknown dose number of  BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot#), single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. The patient had rhinorrhea (runny nose), and oropharyngeal pain (sore throat), with outcome of unknown. Additional information: The reporter's colleague developed symptoms on Saturday night. Symptoms included runny nose and sore throat. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Feel sick; Shivering so severely / thought she would chip a tooth; Hands were shaking so violently / could not brush her teeth; Extremely cold / had to have heating pads; Could not get out of bed / so fatigued / tired; Not feeling well / still does not feel completely well; Fever; Diarrhea; This case was reported by a consumer and described the occurrence of sickness in a 73-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 9th October 2020, the patient received the 1st dose of Shingrix. On 9th October 2020, less than a day after receiving Shingrix, the patient experienced sickness, shivering, tremor of hands, coldness, fatigue, feeling unwell and fever. In October 2020, the patient experienced diarrhea. On an unknown date, the outcome of the sickness and tremor of hands were unknown and the outcome of the shivering, feeling unwell and fever were recovered/resolved and the outcome of the coldness and diarrhea were resolved with sequelae and the outcome of the fatigue was recovering/resolving.   It was unknown if the reporter considered the sickness, shivering, tremor of hands, coldness, fatigue, feeling unwell, fever and diarrhea to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient was started to felt at that evening of vaccination. By bedtime she was shivering so severely that she thought she would chip a tooth, it was that severe. Her hands were shaking so violently that she could not brush her teeth. The patient was extremely cold and had to have heating pads place on her by her husband. The next day she could not get out of bed she was so fatigued but the shivering resolved.  On 12th October 2020 she could get out of bed but was  tired and not feeling well. She had a fever that lasted 2 days.  The diarrhea lasted one day.  All reported symptoms expereinced on 9th October 2020 and on next day and on suday symptoms were progressed. By Monday she felt better but it took 2-3 weeks and before she could function. The patient said at the time of reporting that she did not feel completely well. The reporter consented to follow up.
Sore Arm (left); This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Sore Arm (left)) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced INJECTION SITE PAIN (Sore Arm (left)). At the time of the report, INJECTION SITE PAIN (Sore Arm (left)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported No treatment medication were reported.
I woke up to severe shoulder pain. I have had limited used in my left arm. In certain movements cry out in pain. My shoulder pain is nonstop. I am just in my first week of severe shoulder pain when I researched and found this info.  (I was told i needed 4 shots by health dept., not knowing what to do - i agreed to get them if my insurance would pay for them, thinking what could it hurt) the nurse was very tall, "standing above me" in an office not the usual lab area" told me to hand my arm down "almost touching the floor" so my muscle would be loose- i never questioned her except in my own mind, until now!!! I have NEVER had any shoulder injury or pain in my shoulder. I have been explaining to family how it feels more like a shoulder injury rather than a soreness  from a shot- I've been dumbfounded and in PAIN ALL WEEK. I don't even know what to do -Will start by going to the doctor and i imagine have to have a MRI--
I run on the regular I noticed I was having dizziness, shortness of breath. I was unable to walk up the stairs without shortness of breath. I then reached out to a doctor and was told that my heart was having communication issues with a block to the top chamber. I am now on a pacemaker because of the issues. I went from running marathons to now being limited to so much.
Information has been received from a medical assistant concerning a 16 year old female with no known pertinent medical history and drug reaction, who on 13-NOV-2007 was vaccinated with the first dose of GARDASIL vaccine (yeast). On 28-JAN-2008, the patient was vaccinated with the second dose of GARDASIL vaccine (yeast). On 04-AUG-2008, the patient was vaccinated with the third dose of GARDASIL vaccine (yeast) (Lot # 650391/0063X), 0.5 ml, via intramuscularly route. There was no concomitant medication. The medical assistant was reported that the patient experienced heavy and difficult periods after received GARDASIL vaccines (yeast). The patient also reported to had more severe cramps with menstruation than before. The patient was seen by a nurse. At the time of the report the patient had not recovered. Additional information has been requested.
Subsequent to receiving vax, the pts experienced nodules at the injection site that were like and induration. The induration was often there at the next dose two months later. No further information is available.